There is evidence to demonstrate that insulin is the antidiabetic agent with the greatest glucose-lowering capacity, and epidemio-logical studies have shown its benefits in terms of improving glycemic control and reducing the risk of long-term diabetic complications in type 1 and type 2 diabetes (10). Here, INS is linked to type 2 diabetes mellitus.